The impact of early use of statin in sepsis patients with acute kidney injury: a study based on MIMIC-IV
Der Einfluss eines frühen Statin-Einsatzes bei Sepsispatient:innen mit akuter Nierenverletzung: eine Studie auf Basis von MIMIC-IV
Frontiers in Pharmacology · 20.06.2025 · 16
DOI: 10.3389/fphar.2025.1610450 ↗Auf einen Blick
Bei Sepsis-assoziierter akuter Nierenverletzung war ein früher Statin-Einsatz mit geringerer 28-Tage- und 90-Tage-Mortalität sowie besserer Nierenfunktion assoziiert. Die ICU-Verweildauer war länger.
Fragestellung
Welchen Zusammenhang hat die frühe Gabe von Statinen mit Prognose, Nierenfunktions-Erholung und ICU-Verweildauer bei SA-AKI?
Methode
Datenauswertung aus MIMIC-IV; Einteilung in Statin- und Nicht-Statin-Gruppe nach Statin-Gabe innerhalb von 48 h; Propensity-Score-Matching; time-dependent Cox-, logistische und negative-binomiale Regression.
Ergebnisse
11.667 Patient:innen. Nach Matching 1.585 pro Gruppe. Statine waren mit reduzierter 28-Tage- und 90-Tage-Mortalität und besserer Nierenfunktions-Erholung assoziiert; ICU-Stay verlängert.
Schlussfolgerung der Autor:innen
Bei Sepsispatient:innen mit AKI war der frühe Einsatz von Statinen mit einer geringeren 28-Tage- und 90-Tage-Mortalität verbunden und hatte eine protektive Rolle.
Kernaussagen
- 11.667 Patient:innen aus MIMIC-IV
- Frühe Statin-Gabe: geringere 28-Tage- und 90-Tage-Mortalität
- ICU-Verweildauer unter Statinen länger
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.06.2025. Verfasst von Xiaona Zhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Nanshan People's Hospital, Shenzhen, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Program.
Themen: Sepsis
Abstract (Originalsprache)
Objective
Sepsis-associated acute kidney injury (SA-AKI) is a prevalent and serious condition in the ICU. The efficacy of statin in these patients remains unclear. The purpose of this study was to investigate the impact of the early use of statin on the prognosis of SA-AKI patients.
Methods
The patients included in this study were derived from the MIMIC-IV database. Patients were divided into the non-statin and statin groups based on whether they received statin within 48 h of admission. After propensity score matching, time-dependent Cox regression analysis was used to evaluate the relationship between the early use of statin and mortality. The relationship between treatment and the recovery of renal function was assessed by logistic analysis, and the association between the use of statin and length of ICU stay was evaluated by the negative binomial regression model.
Results
A total of 11,667 patients were included in the study. After propensity score matching, there were 1,585 patients in each group, and the baselines between the two groups were comparable. Although statin use was associated with prolonged ICU stay, it was significantly linked to reduced 28-day and 90-day mortality and improved renal function recovery. Subgroup analysis indicated that the protective effect of early statin use was more effective in patients with hypertension. In comparison with the non-statin group, the use of different types of statin were associated with reduced 28-day mortality in sepsis patients with AKI. Compared with the rosuvastatin group, there was no significant difference in reducing the risk of mortality among other types of statins.
Conclusion
In sepsis patients with AKI, the early use of statin was associated with a reduction in 28-day and 90-day mortality. The early use of statin plays a protective role in patients with SA-AKI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen Nanshan People's Hospital, Shenzhen, China.
Förderung
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Zhan, X., Huang, H., Ye, L., Zhu, S., & Chen, J. (2025). The impact of early use of statin in sepsis patients with acute kidney injury: a study based on MIMIC-IV. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1610450
Vancouver
Zhan X, Huang H, Ye L, Zhu S, Chen J. The impact of early use of statin in sepsis patients with acute kidney injury: a study based on MIMIC-IV. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1610450
BibTeX
@article{Zhan2025,
author = {Zhan, Xiaona and Huang, Haifeng and Ye, Ling and Zhu, Shenglang and Chen, Jiehui},
title = {The impact of early use of statin in sepsis patients with acute kidney injury: a study based on MIMIC-IV},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1610450}
}
EUVIMED